US woes, designated stocks hog limelight
ON THE external front, the main issue that drove stock prices this past week was whether bickering US politicians would be able to reach a compromise on the country's finances. As it turned out, there were flickering signs they might, though as of Thursday in the US, nothing was confirmed yet.
On the home front, the talking point was the Singapore Exchange's (SGX's) labelling of three speculative stocks, namely Asiasons Capital, Blumont and LionGold, as designated securities, which means purchases have to be paid for upfront and "contra" trading is not allowed.
Predictably, all three crashed spectacularly. There was also spillover impact on the rest of the penny segment, not surprisingly leading to criticisms from retail brokers, many of whom rely on trading penny stocks to supplement declining income and may have been wrong-footed by the SGX's actions.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China’s Zeekr prices US IPO at top of range to raise US$441 million
Hin Leong founder OK Lim found guilty of 3 criminal charges
New weight-loss, diabetes drugs reach one in eight Americans
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Manulife profit beats on growth in Asia, wealth management
Sanofi inks US$1.2 billion vaccine licensing deal with Novavax